4-Acetylantroquinonol B Suppresses Prostate Cancer Growth and Angiogenesis via a VEGF/PI3K/ERK/mTOR-Dependent Signaling Pathway in Subcutaneous Xenograft and In Vivo Angiogenesis Models

4-Acetylantroquinonol B Suppresses Prostate Cancer Growth and Angiogenesis via a VEGF/PI3K/ERK/mTOR-Dependent Signaling Pathway in Subcutaneous Xenograft and In Vivo Angiogenesis Models

Prostate cancer is a major cause of cancer-related mortality in men in developed countries. The compound, 4-acetylantroquinonol B (4AAQB), is isolated from <i>Antrodia cinnamomea</i> (commonly known as Niu-Chang-Chih), which has been shown to inhibit cancer growth. However, the anticance...

Full description

Bibliographic Details
Main Authors: Tur-Fu Huang, Shih-Wei Wang, Yu-Wei Lai, Shih-Chia Liu, Yu-Jen Chen, Thomas Y. Hsueh, Chih-Chung Lin, Chun-Hsuan Lin, Ching-Hu Chung
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:International Journal of Molecular Sciences
Subjects:
prostate cancer
<i>Antrodia cinnamomea</i>
4AAQB
metastasis
VEGF
angiogenesis
Online Access:https://www.mdpi.com/1422-0067/23/3/1446

Internet

https://www.mdpi.com/1422-0067/23/3/1446

Similar Items